Evolus (EOLS) Retained Earnings (2018 - 2026)
Evolus' (EOLS) quarterly Retained Earnings came in at $643.2 million in Q1 2026, up 76763.89% YoY from N/an in Q1 2025, and up 412414.1% on a QoQ basis from -$156000.0 in Q4 2025.
Evolus (EOLS) Retained Earnings (2018 - 2026) Analysis & Trends
Evolus (EOLS) has 9 years of Retained Earnings data on file, last reported at $643.2 million in Q1 2026.
- Quarterly Retained Earnings rose 76763.89% year-over-year to $643.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $643.2 million (up 76763.89% YoY) and the FY2025 annual result came in at -$156000.0, down 100.03% from the prior year.
- Retained Earnings rose to $643.2 million in Q1 2026, from -$156000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $643.2 million in Q1 2026 to a low of -$602.6 million in Q3 2024.
- A 5-year average of $140.0 million and a median of -$103000.0 in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 504419.42% in 2023, down 208.3% in 2023.
- Tracing EOLS's Retained Earnings over 5 years: stood at $516.1 million in 2022, then slumped by 208.3% to -$559.0 million in 2023, then surged by 210.17% to $615.8 million in 2024, then tumbled by 100.03% to -$156000.0 in 2025, then jumped by 412414.1% to $643.2 million in 2026.
- The last three Retained Earnings figures came in at $643.2 million (Q1 2026), -$156000.0 (Q4 2025), and $632.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.42 Bn | 43.46 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.71 Bn | 40.06 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.41 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | 3.75 Bn |
| 10 | Evolus | 556.44 Mn | 511.27 Mn | 57.18 Mn | -679.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -679.77 Mn |
| Mar 31, 2026 | 643.21 Mn |
| Dec 31, 2025 | -156,000.00 |
| Sep 30, 2025 | 632.55 Mn |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | -839,000.00 |
| Dec 31, 2024 | 615.83 Mn |
| Sep 30, 2024 | -602.61 Mn |
| Jun 30, 2024 | -601,000.00 |
| Mar 31, 2024 | 591.09 Mn |
| Dec 31, 2023 | -558.98 Mn |
| Sep 30, 2023 | -547.15 Mn |
| Jun 30, 2023 | 523.73 Mn |
| Mar 31, 2023 | 519.45 Mn |
| Dec 31, 2022 | 516.13 Mn |
| Sep 30, 2022 | 513.72 Mn |
| Jun 30, 2022 | -463.85 Mn |
| Mar 31, 2022 | -103,000.00 |
| Dec 31, 2021 | 504.76 Mn |
| Sep 30, 2021 | -404.71 Mn |